REVIEW
|
doi:10.20944/preprints202401.1697.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
DOAC; FXIa; mAbs; ASO; drug-drug interactions
Online: 23 January 2024 (12:31:04 CET)
CONCEPT PAPER
|
doi:10.20944/preprints202004.0412.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
coronavirus; COVID-19; antisense oligonucleotide; ASO; LNA GapmeR
Online: 23 April 2020 (11:30:39 CEST)
REVIEW
|
doi:10.20944/preprints202409.2440.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
amyotrophic lateral sclerosis (ALS); superoxide dismutase 1 (SOD1); antisense oligonucleotide (ASO); tofersen; central nervous system
Online: 30 September 2024 (14:42:20 CEST)
REVIEW
|
doi:10.20944/preprints202405.0274.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
cell-penetrating peptides (CPP); antisense oligonucleotides (ASO); spinal muscular atrophy (SMA); delivery; phosphorodiamidate morpholino oligomers (PMO); DG9
Online: 6 May 2024 (09:54:35 CEST)
REVIEW
|
doi:10.20944/preprints202302.0429.v1
Subject:
Medicine And Pharmacology,
Dermatology
Keywords:
RNA therapeutics; skin; mRNA therapeutics; siRNA therapeutics; antisense oligonucleotide ther-apeutics; ASO; melanoma; hypertrophic scars; wound healing; dermatology
Online: 27 February 2023 (01:53:06 CET)
REVIEW
|
doi:10.20944/preprints202406.2068.v1
Subject:
Biology And Life Sciences,
Neuroscience And Neurology
Keywords:
spinal muscular atrophy (SMA); survival of motor neuron 1 (SMN1); SMN2; SMN protein; antisense oligonucleotide (ASO); nusinersen; gene therapy; onasemnogene; risdiplam; small molecule; combination therapy
Online: 29 June 2024 (06:33:01 CEST)